All stock lists
Unlock the score
Veru Inc. (NASDAQ:VERU)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
2.21-0.03 (-1.34%)
Market cap
$37.7M
Insider Score
Health Score
Analyst consensus
Listed since
Feb 11, 1999
Website
Insider Score
/ 100
VERU Insider Score
VERU INC. has a live Insider Score.
Scored on 1 qualifying trade from 1 insider in the last 90 days.
Financial Health Score
Fair
From VERU’s reported statements · Q2 2026 (trailing 12 months) · 4 of 5 pillars
Profitability—
No revenue reported, so there is no margin to score.
- Revenue
- $0
- Net income
- -$13.6M
- Net margin
- —
Leverage19 / 20
Little or no net debt.
- Total debt
- $2.7M
- Cash
- $23.9M
- Debt / equity
- 0.09
Liquidity20 / 20
Comfortably covers what is due within a year.
- Current assets
- $27.2M
- Current liabilities
- $6.2M
- Current ratio
- 4.42
Cash generation3 / 20
Consumes cash and must keep raising it.
- Operating cash flow
- -$26.0M
- Free cash flow
- -$26.0M
Dilution & runway0 / 20
Burning cash with under a year of runway — expect a raise.
- Shares outstanding
- 23.1M
- Share growth (1y)
- 57.3%
- Cash runway
- 11 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
VERU Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Growth (YoY) | — | — | — | -100.00 % | -100.00 % | -100.00 % |
| Cost of Revenue | 0.00 | 28.19 K | 28.19 K | 0.00 | 0.00 | 29.33 K |
| Gross Profit | 0.00 | -28.19 K | -28.19 K | 0.00 | 0.00 | -29.33 K |
| SG&A Expense | 3.36 M | 4.07 M | 4.08 M | 4.54 M | 5.01 M | 5.16 M |
| R&D Expense | 4.35 M | 3.15 M | 1.34 M | 2.92 M | 3.02 M | 3.93 M |
| Operating Expenses | 7.71 M | 7.22 M | 5.40 M | -1.17 M | 7.55 M | 8.12 M |
| Operating Income | -7.71 M | -7.22 M | -5.42 M | 1.17 M | -7.55 M | -8.12 M |
| Pretax Income | -6.99 M | -3.09 M | -5.33 M | 1.30 M | -7.32 M | -7.85 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -6.99 M | -2.74 M | -5.33 M | 1.45 M | -7.33 M | -7.90 M |
| EPS (Basic) | -0.30 | -0.13 | -0.26 | 0.09 | -0.50 | -0.54 |
| EPS (Diluted) | -0.30 | -0.13 | -0.26 | 0.09 | -0.50 | -0.54 |
| Shares Outstanding | 23.05 M | 21.66 M | 20.31 M | 14.65 M | 14.66 M | 14.64 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.